QTTB Q2 2021 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena

QTTBQ32 Bio Inc.

$83M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+285.7% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$31M-1397.0% margin

Net Income

-$31M-1394.6% margin

EPS (Diluted)

$-9.72

QoQ Revenue Growth

-92.5%

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$25M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$259M

Total Liabilities

$34M

Stockholders' Equity

$225M

Cash & Equivalents

$116M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$567,000	+285.7%
Gross Profit	$2M	$0	—
Operating Income	-$31M	-$36M	+14.4%
Net Income	-$31M	-$35M	+13.7%